Chidamide-maintained long-term clinical remission with persistent T-Cell clone in refractory T-LGL leukemia-associated pure red cell aplasia: A six-year follow-up

Huan Tao, Nenggang Jiang, Yongqian Jia

Open source

DOI
10.1016/j.lrr.2026.100605
Published
2026
Container
Leukemia Research Reports
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.lrr.2026.100605,
  title = {Chidamide-maintained long-term clinical remission with persistent T-Cell clone in refractory T-LGL leukemia-associated pure red cell aplasia: A six-year follow-up},
  author = {Huan Tao and Nenggang Jiang and Yongqian Jia},
  year = {2026},
  journal = {Leukemia Research Reports},
  doi = {10.1016/j.lrr.2026.100605},
  url = {https://doi.org/10.1016/j.lrr.2026.100605}
}

RIS

TY  - JOUR
TI  - Chidamide-maintained long-term clinical remission with persistent T-Cell clone in refractory T-LGL leukemia-associated pure red cell aplasia: A six-year follow-up
AU  - Huan Tao
AU  - Nenggang Jiang
AU  - Yongqian Jia
PY  - 2026
JO  - Leukemia Research Reports
DO  - 10.1016/j.lrr.2026.100605
UR  - https://doi.org/10.1016/j.lrr.2026.100605
ER  - 

APA

Tao, H., Jiang, N., & Jia, Y. (2026). Chidamide-maintained long-term clinical remission with persistent T-Cell clone in refractory T-LGL leukemia-associated pure red cell aplasia: A six-year follow-up. Leukemia Research Reports. https://doi.org/10.1016/j.lrr.2026.100605

Source records